XML 167 R123.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK PROGRAMS - Summary of Stock Option Programs (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Company Stock Option Plan  
Shares  
Outstanding at the beginning of the year (in shares) | shares 7,171,800
Grant at fair value (in shares) | shares 1,234,800
Exercised (in shares) | shares (739,000.0)
Expired (in shares) | shares (41,400)
Forfeited (in shares) | shares (129,100)
Outstanding at the end of the period (in shares) | shares 7,497,100
Vested and expected to vest (in shares) | shares 7,440,500
Exercisable (in shares) | shares 5,398,400
Weighted-Average Exercise Price Per Share  
Outstanding at the beginning of the year (in dollars per share) | $ / shares $ 169.20
Weighted-average grant date fair value (in dollars per share) | $ / shares 246.01
Exercise price (in dollars per share) | $ / shares 119.56
Expired (in dollars per share) | $ / shares 283.87
Forfeited (in dollars per share) | $ / shares 268.04
Outstanding at the end of the period (in dollars per share) | $ / shares 184.41
Vested and expected to vest Weighted-Average Exercise Price (in dollars per share) | $ / shares 183.78
Exercisable Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 151.96
Additional General Disclosures  
Outstanding Aggregate Intrinsic Value (in dollars) | $ $ 318
Outstanding, Weighted-Average Contractual Life Remaining 6 years
Vested and expected to vest, Aggregate Intrinsic Value (in dollars) | $ $ 318
Vested and expected to vest, Weighted-Average Contractual Life Remaining 6 years
Exercisable, Aggregate Intrinsic Value (in dollars) | $ $ 318
Exercisable, Weighted-Average Contractual Life Remaining 5 years
DECIEM 2021 Stock Option Plan  
Shares  
Outstanding at the beginning of the year (in shares) | shares 94,100,000
Grant at fair value (in shares) | shares 0
Exercised (in shares) | shares 0
Expired (in shares) | shares 0
Forfeited (in shares) | shares 0
Outstanding at the end of the period (in shares) | shares 94,100,000
Vested and expected to vest (in shares) | shares 94,100,000
Exercisable (in shares) | shares 0
Weighted-Average Exercise Price Per Share  
Outstanding at the beginning of the year (in dollars per share) | $ / shares $ 60.11
Weighted-average grant date fair value (in dollars per share) | $ / shares 0
Exercise price (in dollars per share) | $ / shares
Expired (in dollars per share) | $ / shares
Forfeited (in dollars per share) | $ / shares
Outstanding at the end of the period (in dollars per share) | $ / shares 58.48
Vested and expected to vest Weighted-Average Exercise Price (in dollars per share) | $ / shares 58.48
Exercisable Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 0
Additional General Disclosures  
Outstanding Aggregate Intrinsic Value (in dollars) | $ $ 104
Outstanding, Weighted-Average Contractual Life Remaining 11 months 1 day
Vested and expected to vest, Aggregate Intrinsic Value (in dollars) | $ $ 104
Vested and expected to vest, Weighted-Average Contractual Life Remaining 11 months 1 day
Exercisable, Aggregate Intrinsic Value (in dollars) | $ $ 0
Exercisable, Weighted-Average Contractual Life Remaining 0 years